Research News and Research

RSS

Green nanotechnology from tea

Researchers from the University of Missouri-Columbia report in the Journal of Materials Chemistry that chemicals in tea are the best yet discovered to make consistent, biologically safe gold nanoparticles. More importantly, these gold nanoparticles show promising anticancer properties.

27 Apr 2009

Countries unite to reduce animal use in product toxicity testing worldwide

Representatives from four international agencies, including the director of the U.S. National Toxicology Program (NTP), today signed a memorandum of cooperation that could reduce the number of animals required for consumer product safety testing worldwide.

27 Apr 2009

New scan may lead to better treatment for epilepsy

Australian scientists have found that new technology may help in the treatment of epilepsy.

27 Apr 2009

Test for best potential HIV/AIDS vaccine in the pipeline

Scientists in Britain are well on the way to developing a test for the best potential HIV/AIDS vaccine.

27 Apr 2009

Australian researchers win bumper grant from Bill Gates for HIV research

Australian researchers have won themselves a bumper grant from the Bill & Melinda Gates Foundation to examine the best way of using drugs to treat HIV.

27 Apr 2009

Tadalafil may improve lower urinary tract symptoms in men with benign prostatic hyperplasia

Relative symptom improvement in the IPSS also was significantly better in the tadalafil group. At the end of the study, the proportion of obstructed patients in the placebo group increased, while the proportion in the tadalafil group decreased.

26 Apr 2009

Combination of vitamin E, selenium and soy does not prevent prostate cancer

The combination therapy of vitamin E, selenium and soy does not prevent the progression from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer, according to the new research presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA).

26 Apr 2009

Research brings new hope, old problems with Alzheimer's disease biomarkers

Brain imaging and cognitive tests may be the gold standards for tracking Alzheimer disease progression, but clinical trials using these procedures are expensive, risky, and time-consuming, making the development of reliable go-betweens a pressing goal for AD researchers.

26 Apr 2009

Cholesterol-lowering drugs may reduce inflammation in prostate tumors

Cholesterol-lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center.

26 Apr 2009

Cancer incidence, mortality, treatment and survival in Ireland

Survival rates for cancer are continuing to rise even though the number of cases being diagnosed is increasing, an all-Ireland report reveals.

26 Apr 2009

Scientists improve immune response to cancer

A team of scientists at The Campbell Family Institute for Breast Cancer Research (CFIBCR) at Princess Margaret Hospital and international collaborators have discovered how to trigger an improved immune response to cancer that could be included in new clinical trials that use a patient's own cells to destroy tumours.

26 Apr 2009

New diagnostic technique found for most common bladder tumors

Making tumors inside the bladder fluoresce red under blue light allows physicians to more easily find and remove them, substantially reducing the rate at which these cancers come back, says a Mayo Clinic physician who is presenting results of a large, multicenter international clinical trial.

26 Apr 2009

Predominant risk factors for first urinary tract infections in college-aged women

Increased sexual activity and alcohol consumption were associated with an increased risk of developing urinary tract infections (UTIs), and college-aged women experiencing urinary frequency or urgency should seek medical care to treat what may be their first urinary tract infection (UTI), according to new research presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA)

26 Apr 2009

Statins may benefit men with prostate cancer, erectile dysfunction or lower urinary tract symptoms

Several new studies presented at the American Urological Association's (AUA) 104th Annual Scientific Meeting suggest that the use of statins - commonly prescribed to lower cholesterol - may benefit men with prostate cancer, erectile dysfunction or lower urinary tract symptoms (LUTS).

26 Apr 2009